403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Appili Therapeutics Inc.
(MENAFN- Baystreet) 10:17 AM EST - Appili Therapeutics Inc. : Today announced that, the Company along with its partners, have submitted applications for four new federal funding opportunities. The funding, if awarded, would total up to US$117.5 million and support the company's efforts to advance urgent infectious disease treatments aligned with critical public health priorities. Appili Therapeutics Inc.
shares T are trading unchanged at $0.03.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment